Companies / North Carolina / Pelthos Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Pelthos Therapeutics? Who to reach and why now

Pelthos Therapeutics is a publicly listed pharmaceuticals company in Durham, North Carolina, founded 2021. It raised $57.5M in Oct 2026 and its filings name 11 officers. Everything below links to the record it came from.

Listed company · Pharmaceuticals · North Carolina

Reach the people at Pelthos Therapeutics

Get verified emails for the people you need at Pelthos Therapeutics

Why now: Signed a material agreement, Oct 30, 2026.

Lakewave is an AI sales intelligence platform. It watches public records for buying signals, finds who holds each role today, verifies their email and drafts the first message.

Free trial · no credit cardStart free with the full platformTrack Pelthos Therapeutics and accounts like it, get the next signal the day it is filed, see who to reach, and send AI-drafted outreach from your own inbox.Start free →
Reach Pack · no subscriptionJust need the emails?From 16 cents per verified email, no subscription, for when you only need the emails.Reach people at Pelthos Therapeutics →

Work email required. Only verified emails are charged, and a search that finds nobody costs nothing. Credits never expire. No subscription.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerScott PleshaSEC filing, Oct 2026Named officer in the filing; part of the buying group
Executive OfficerJohn M. GaySEC filing, Oct 2026Named officer in the filing; part of the buying group
Executive OfficerSai RangaraoSEC filing, Oct 2026Named officer in the filing; part of the buying group
Executive OfficerPeter GreenleafSEC filing, Oct 2026Named officer in the filing; part of the buying group
Executive OfficerFrancis Knuettel IISEC filing, Nov 2025Named officer in the filing; part of the buying group
Chief Technology OfficerRichard BaxterSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerEzra FriedbergSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerTodd DavisSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerRichard MalamutSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerMatthew PaulsSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerAndrew EinhornSEC filing, Oct 2026Technology and tooling decisions
For sellersWhy Pelthos Therapeutics is worth a call this quarterBuy Window: open · major agreement Oct 2026
Oct 2026Oct 2026

Corporate event

Signed a material agreement

Corporate event
Oct 30Oct 2026

New leadership

Officer or director change

New leadership
$57.5M

Raised

Equity raise reported to the SEC, Oct 2026. Money arrives before the spending plan does.

Capital
Track Pelthos Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Pelthos Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 30, 2026Signed a material agreementCorporate eventSEC filing
Oct 30, 2026Officer or director changeNew leadershipSEC filing
Oct 30, 2026Raised $57.5M in equity from 7 investorsCapitalSEC filing
Sep 29, 2026Officer or director changeNew leadershipSEC filing
Nov 6, 2025Raised $18M in equity from 8 investorsCapitalSEC filing
Jul 1, 2025Raised $50.1M in equity from 13 investorsCapitalSEC filing

Reach Pelthos Therapeutics with emails that land

Lakewave finds the right people at Pelthos Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Pelthos Therapeutics with a free trial →

About Pelthos Therapeutics

HeadquartersDurham, North Carolina, per the filing address
Industry groupPharmaceuticals
Founded2021, NEVADA
OwnershipListed company
Raise history$50.1M (Jul 2025) · $18M (Nov 2025) · $57.5M (Oct 2026)
Lakewave Rising44 · 3 kinds of evidence · rank in North Carolina after sign-up

Questions people ask

Did Pelthos Therapeutics raise funding in 2026?

Yes. Pelthos Therapeutics reported a $57.5M equity raise to the SEC on Oct 30, 2026 with 7 investors.

Who runs Pelthos Therapeutics?

The company's SEC filing, Oct 2026 names Scott Plesha (Executive Officer) among its officers.

Is Pelthos Therapeutics hiring?

Yes. 2 roles were open on its careers page on Nov 17, 2026.

Where is Pelthos Therapeutics headquartered?

Durham, North Carolina, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 17, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.